October 2006: Lipoic Acid for Diabetes Complications
However, in October 2006, researchers at Heinrich-Heine-University in Dusseldorf, Germany reported a study that does support oral use of lipoic acid. In this
Researchers defined "responders" as those who attained a greater than 50% improvement in a measure of overall symptom severity, the TSS score. By the end of the five-week study period, more than half the participants given lipoic acid achieved this level of improvement compared to only about one quarter of those given placebo. To look at this another way, on average, participants given lipoic acid achieved more improvement than those given placebo, according to most individual measures of symptom severity.
Somewhat surprisingly, the best results were seen in those taking the lowest dose of lipoic acid. Not only were improvements somewhat greater, but there were less side effects. People taking higher doses of lipoic acid were more likely to experience nausea and vomiting.
These are quite promising findings. However, all major studies on lipoic acid for peripheral neuropathy have been performed by a single group of researchers. Research by independent groups is needed before lipoic acid can be considered a proven treatment for diabetic peripheral neuropathy.
Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care . 2006;29:2365-2370.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.